D Ogston, A S Douglas. Show Affiliations »
Abstract
Mesh: See more » Administration, OralAdultAnticoagulants/administration & dosageAnticoagulants/adverse effectsAnticoagulants/pharmacologyAnticoagulants/therapeutic useBlood Coagulation FactorsCoronary Disease/drug therapyCoumarins/pharmacologyDipyridamole/therapeutic useDisseminated Intravascular Coagulation/drug therapyDrug AntagonismDrug HypersensitivityDrug InteractionsDrug SynergismFemaleFibrinolytic Agents/therapeutic useHemorrhage/chemically inducedHeparin/therapeutic useHumansMaleMiddle AgedMyocardial Infarction/drug therapyPhlebitis/drug therapyPlatelet Adhesiveness/drug effectsPostpartum Period/drug effectsPregnancy/drug effectsPulmonary Embolism/drug therapyThrombophlebitis/drug therapyTime Factors
Substances: See more » AnticoagulantsBlood Coagulation FactorsCoumarinsFibrinolytic AgentsDipyridamoleHeparin
Year: 1971 PMID: 4939607 DOI: 10.2165/00003495-197101040-00003
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546